Immunophenotype, as determined by FACS analysis, of patient peripheral blood mononuclear cells (PBMCs) circulating at day +45 after PBSC transplantation (PBMC–ex vivo) or after a single round of in vitro stimulation with donor PBMC (TCL + 1)
| Responder . | No. st . | Positive cells, % . | |||||
|---|---|---|---|---|---|---|---|
| CD3+ . | CD4+ . | CD8+ . | CD56+ . | CD19+ . | HLA-A2+ . | ||
| PBMC–ex vivo | 0 | 88.7 | 9.4 | 80.2 | 4.7 | 0 | 86.7 |
| TCL + 1 | 1 | ND | 98.6 | 0.5 | ND | ND | 97.9 |
| Responder . | No. st . | Positive cells, % . | |||||
|---|---|---|---|---|---|---|---|
| CD3+ . | CD4+ . | CD8+ . | CD56+ . | CD19+ . | HLA-A2+ . | ||
| PBMC–ex vivo | 0 | 88.7 | 9.4 | 80.2 | 4.7 | 0 | 86.7 |
| TCL + 1 | 1 | ND | 98.6 | 0.5 | ND | ND | 97.9 |
No. st indicates the number of in vitro stimulations; ND, not done.